Business Context and Reporting Period
InflaRx N.V., a foreign private issuer, filed this Form 6-K on May 7, 2026, to report the completion of an underwritten public offering of ordinary shares. The offering closed on May 7, 2026, following an Underwriting Agreement entered into on May 6, 2026, with Guggenheim Securities, LLC, as representative of the underwriters.
Key Financial Metrics
- Shares Issued: 75,000,000 ordinary shares (nominal value €0.12 per share).
- Offering Price: $2.00 per share.
- Gross Proceeds: Approximately $150 million (before deducting underwriting discount and estimated offering expenses).
- Net Proceeds: The filing text does not provide a clear value for net proceeds after expenses.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational or balance sheet metrics.
Material Changes
The primary material change reported is the significant increase in the Company's share count and capitalization resulting from the issuance of 75,000,000 new ordinary shares. This transaction was conducted pursuant to an effective shelf registration statement on Form F-3 (File No. 333-273058).
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future operations, or a discussion of risks beyond standard legal indemnification clauses. The Company has agreed to indemnify the Underwriters against certain liabilities under the Securities Act of 1933. The text notes that the description of the Underwriting Agreement is qualified by reference to the complete text filed as Exhibit 1.1.
Investor Verification Checklist
- Verify the exact amount of underwriting discounts and offering expenses to determine net proceeds.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific terms, conditions, and indemnification details.
- Confirm the dilution impact of the 75,000,000 new shares on existing shareholders.
- Check subsequent filings for the intended use of the approximately $150 million in gross proceeds.